SCHEMBL21252344

SCHEMBL21252344

COc1cc(OC)c(Cl)c(-c2cc3cnc(N)cc3c(N3CCOCC3)n2)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 6/20 0.47
▸ MTOR P42345 6/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ FGFR1 P11362 1/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ MAP2K7 O14733 1/20 0.39
▸ TRPM8 Q7Z2W7 2/20 0.39
▸ GAK O14976 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ LRRK2 Q5S007 2/20 0.38
▸ PIK3R1 P27986 3/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ RICTOR Q6R327 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21252286 0.90 SMN1; SMN2 (0.40) PIK3CAMTORSMN1; SMN2FGFR1ALDH1A1
SCHEMBL21252341 0.90 SMN1; SMN2 (0.43) PIK3CAMTORSMN1; SMN2FGFR1MAP2K7
SCHEMBL20332257 0.89 SMN1; SMN2 (0.48) PIK3CAMTORSMN1; SMN2FGFR1PDE10A
SCHEMBL21252340 0.88 PIK3CA (0.47) PIK3CAMTORSMN1; SMN2FGFR1PDE10A
SCHEMBL21251915 0.87 TTK (0.37) PIK3CAMTORSMN1; SMN2FGFR1FGFR3
SCHEMBL21252329 0.86 GAK (0.40) PIK3CAMTORSMN1; SMN2FGFR1PDE10A
SCHEMBL21252058 0.86 FGFR4 (0.40) PIK3CAMTORFGFR1PDE10A
SCHEMBL21252481 0.86 FGFR4 (0.40) FGFR1
SCHEMBL21252093 0.85 PDE10A (0.38) PIK3CAMTORFGFR1PDE10AFGFR3
SCHEMBL21251782 0.85 PIK3CA (0.36) PIK3CAMTORSMN1; SMN2FGFR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-B1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF ABBISKO THERAPEUTICS CO LTD (CN) 2022-06-08 — — EP disclosed
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 — — EP disclosed
Send feedback